lactic acid has been researched along with epigallocatechin gallate in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 13 (86.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Haramizu, S; Murase, T; Nagasawa, A; Shimotoyodome, A; Tokimitsu, I | 1 |
Araújo, I; Correia-Branco, A; Costa, T; Faria, A; Keating, E; Martel, F; Moreira, L | 1 |
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M; Srivastava, AK | 1 |
Manzoor, K; Menon, D; Mohan, CC; Narayanan, D; Narayanan, S; Pavithran, M; Viswanath, A | 1 |
Moustaid-Moussa, N; Nie, S; Su, R; Sun, M; Wang, S; Wu, D; Zhang, J | 1 |
Han, DW; Hyon, SH; Kim, HL; Kwon, BJ; Lee, JH; Lee, MH; Park, JC | 1 |
Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A | 1 |
Han, DW; Hyon, SH; Kim, TW; Lee, JH; Oh, JW; Park, JC; Shin, YC; Yang, WJ | 1 |
Baba, N; Baba, S; Hagiwara, K; Kato, Y; Kawabata, K; Natsume, M; Ohigashi, H; Sakano, T; Tamura, A | 1 |
Koyakutty, M; Menon, D; Mony, U; Narayanan, S; Paul-Prasanth, B; Vijaykumar, DK | 1 |
Han, DW; Hyon, SH; Lee, JH; Park, JC; Shin, YC; Yang, WJ | 1 |
Jang, EH; Koo, MA; Kwon, BJ; Lee, MH; Park, JC; Seon, GM | 1 |
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M | 1 |
Bendik, I; Blaak, EE; Goossens, GH; Hospers, JJ; Jocken, J; Most, J; van Can, JG; van Dijk, JW | 1 |
Bracken, RM; Churm, R; Dunseath, G; Prior, SL; Williams, LM | 1 |
2 review(s) available for lactic acid and epigallocatechin gallate
Article | Year |
---|---|
Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Topics: Biological Availability; Catechin; Curcumin; Emulsions; Lactic Acid; Liposomes; Micelles; Nanoparticles; Nanotechnology; Phytochemicals; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Solubility; Stilbenes | 2014 |
Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Curcumin; Drug Carriers; Humans; Lactic Acid; Mice; Nanoparticles; Neoplasms; Phytochemicals; Polyglycolic Acid; Polyhydroxyethyl Methacrylate; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Silicon Dioxide; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
1 trial(s) available for lactic acid and epigallocatechin gallate
Article | Year |
---|---|
The polyphenol epigallocatechin gallate lowers circulating catecholamine concentrations and alters lipid metabolism during graded exercise in man: a randomized cross-over study.
Topics: Catechin; Cross-Over Studies; Exercise; Glucose; Humans; Lactic Acid; Lipid Metabolism; Lipids; Male; Metanephrine; Polyphenols; Single-Blind Method | 2023 |
12 other study(ies) available for lactic acid and epigallocatechin gallate
Article | Year |
---|---|
Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice.
Topics: Adipose Tissue; Animals; Catechin; Dose-Response Relationship, Drug; Energy Metabolism; Fatty Acids; Fatty Acids, Nonesterified; Lactic Acid; Lipid Metabolism; Male; Metabolism; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Organ Size; Oxidation-Reduction; Physical Endurance; Plant Extracts; RNA, Messenger; Swimming; Tea | 2005 |
Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Catechin; Cell Death; Cell Proliferation; Female; Glucose; Humans; Lactic Acid; MCF-7 Cells; Quercetin; Receptors, Estrogen | 2013 |
Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Biflavonoids; Catechin; DNA Damage; DNA Repair; Female; Gene Expression Regulation; Lactic Acid; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Tea | 2013 |
Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics.
Topics: Animals; Biocompatible Materials; Caseins; Catechin; Cell Death; Cell Line; Chromatography, High Pressure Liquid; Cytokines; Humans; Indocyanine Green; Inflammation; Lactic Acid; Materials Testing; Mice; Nanomedicine; Nanoparticles; Organ Specificity; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2014 |
Promotion of full-thickness wound healing using epigallocatechin-3-O-gallate/poly (lactic-co-glycolic acid) membrane as temporary wound dressing.
Topics: Adult; Animals; Antioxidants; Bandages; Catechin; Cell Line; Humans; Lactic Acid; Male; Membranes, Artificial; Mice; Mice, Inbred BALB C; Mice, Nude; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Wound Healing | 2014 |
PLGA nanofiber membranes loaded with epigallocatechin-3-O-gallate are beneficial to prevention of postsurgical adhesions.
Topics: Animals; Catechin; Lactic Acid; Male; Membranes, Artificial; Nanofibers; Partial Thromboplastin Time; Peritoneum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protective Agents; Rats; Rats, Sprague-Dawley; Tissue Adhesions | 2014 |
Effects of phytochemicals on in vitro anti-inflammatory activity of Bifidobacterium adolescentis.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Bifidobacterium; Catechin; Cell Line; Coculture Techniques; Dose-Response Relationship, Drug; Flavonoids; Glucosides; Lactic Acid; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Phytochemicals; Probiotics; Quercetin | 2015 |
Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Caseins; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lactic Acid; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Epigallocatechin-3-O-Gallate-Loaded Poly(lactic-co-glycolic acid) Fibrous Sheets as Anti-Adhesion Barriers.
Topics: Adsorption; Animals; Antioxidants; Bandages; Catechin; Lactic Acid; Male; Materials Testing; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Tissue Adhesions; Treatment Outcome | 2015 |
Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(L-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta.
Topics: Animals; Antioxidants; Aorta, Abdominal; Catechin; Diffusion; Drug Implants; Electroplating; Endothelium, Vascular; Lactic Acid; Male; Membranes, Artificial; Nanocapsules; Nanopores; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Treatment Outcome; Vascular System Injuries | 2015 |
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Cell Count; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Flow Cytometry; Humans; Kinetics; Lactic Acid; Mice; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyphenols; Reactive Oxygen Species; Tea | 2015 |
A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects.
Topics: Adipose Tissue; Catechin; Dietary Supplements; Energy Metabolism; Female; Gene Expression Regulation; Humans; Lactic Acid; Lipolysis; Male; Metabolome; Metabolomics; Muscle, Skeletal; Overweight; Oxidation-Reduction; Time Factors | 2015 |